Medicare’s recent move to cover the weight-loss drug Wegovy for some recipients with heart disease risk could drive up the cost of monthly premiums for millions of enrollees.
Related Posts
‘I am so scared of them now’: Burned from overspending, some ‘buy now, pay later’ users warn others away
After racking up thousands of dollars in debt, som